Your session is about to expire
← Back to Search
Local Anesthetic
Ice Pack and Topical EMLA cream for Laser Hair Removal
N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial tests whether ice packs or numbing cream is better at reducing pain during laser hair removal under the arms. Ice packs work by cooling the skin, and the cream works by blocking pain signals.
Who is the study for?
This trial is for Caucasian or Asian females aged 18-65 with Fitzpatrick skin type I-III and coarse dark axillary hair, who are in good health and can communicate with investigators. It's not for those with certain skin conditions, scarring histories, allergies to lidocaine/prilocaine, bleeding disorders, pregnancy/lactation, mental illnesses or inability to consent.
What is being tested?
The study compares the effectiveness of using an ice pack versus EMLA cream (a numbing cream) to reduce pain during laser hair removal under the arms. This pilot study will assess how feasible these pain control methods are.
What are the potential side effects?
Potential side effects from EMLA may include reactions at the application site like redness or swelling. Ice packs might cause discomfort due to cold temperatures but typically have minimal risks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Ice PackActive Control1 Intervention
Group II: Topical EMLA creamActive Control1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Ice Pack works through cold-induced vasoconstriction and reduced nerve conduction, numbing the area and reducing pain by limiting blood flow and slowing nerve signals. EMLA, a topical anesthetic, blocks sodium channels in nerve cells, preventing the initiation and transmission of nerve impulses, thereby reducing pain sensation.
Understanding these mechanisms helps patients make informed decisions about pain management options during Laser Hair Removal, ensuring a more comfortable experience.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,649 Previous Clinical Trials
958,741 Total Patients Enrolled
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,550 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of cold-induced hives.You have a history of raised and thick scars after injury or surgery.You have a current injury or unusual feeling in your skin.You have had laser treatment in your underarm area in the past.The doctor thinks that you have a medical condition that could affect how you respond to the treatment or that could put you at risk if you participate in the study.You are allergic to lidocaine or prilocaine.You have a history of mental or psychological conditions, such as mood disorders, anxiety disorders, and cognitive disorders.You have a history of frequent small red or purple spots on your skin.You are female.You are 18-65 years old.Subjects must be willing and able to understand and communicate with investigators.You have light to medium skin tone and thick, dark hair under your arms.
Research Study Groups:
This trial has the following groups:- Group 1: Ice Pack
- Group 2: Topical EMLA cream
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.